# reload+after+2024-01-19 21:47:13.069432
address1§560 Sylvan Avenue
address2§Suite 3160
city§Englewood Cliffs
state§NJ
zip§07632
country§United States
phone§718 400 9031
website§https://silopharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. The company's developing solutions to address various underserved conditions. It also seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the benefits they may have in certain cases involving depression, mental health issues, and neurological disorders. The company focuses on merging traditional therapeutics with psychedelic research for people suffering from indications, such as depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.
fullTimeEmployees§3
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Eric  Weisblum', 'age': 53, 'title': 'Chairman, President & CEO', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 332250, 'exercisedValue': 0, 'unexercisedValue': 20130}, {'maxAge': 1, 'name': 'Mr. Daniel E. Ryweck', 'age': 58, 'title': 'Chief Financial Officer', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 57510, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. James S. Kuo M.B.A., M.D.', 'age': 58, 'title': 'Vice President of Research & Development', 'yearBorn': 1965, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.062
priceToSalesTrailing12Months§62.950375
currency§USD
dateShortInterest§1702598400
forwardEps§-0.56
exchange§NCM
quoteType§EQUITY
shortName§Silo Pharma, Inc.
longName§Silo Pharma, Inc.
firstTradeDateEpochUtc§1610116200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§e5777432-809b-362d-a689-efb776f88c93
gmtOffSetMilliseconds§-18000000
targetHighPrice§10.0
targetLowPrice§10.0
targetMeanPrice§10.0
targetMedianPrice§10.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§12.923
grossMargins§0.91903
ebitdaMargins§0.0
trailingPegRatio§None
